Orbital Inflammation in Thyroid Eye Disease: Stress Responses and Their Implications

Orbital Inflammation in Thyroid Eye Disease: Stress Responses and Their Implications

Thyroid Eye Disease (TED) is a debilitating autoimmune condition characterized by significant inflammation of orbital tissues, including the extraocular muscles and adipose tissues. The pathological mechanisms underlying this inflammation involve a complex interplay of stress responses at the cellul...

Full description

Bibliographic Details
Main Authors:	Tracy Aoun, Diana Danielova Gueorguieva, Kevin Y. Wu
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Stresses
Subjects:	thyroid eye disease Graves’ disease Graves’ ophthalmopathy Graves’ orbitopathy stress oxidative stress
Online Access:	https://www.mdpi.com/2673-7140/4/1/4

Similar Items

Graves’ ophthalmopathy – thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019-08-01)

Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
by: Lilly H. Wagner, et al.
Published: (2022-11-01)

An Appraisal of the Preventive Effect of Statins on the Development of Graves’ Ophthalmopathy: A Hospital-Based Cohort Study
by: Grace Chia-Yen Hsu, et al.
Published: (2024-04-01)

Steroid Treatment Focused Management of Graves’ Ophthalmopathy
by: Condeng Y. H., et al.
Published: (2024-09-01)

Orbital Radiotherapy for Graves’ Ophthalmopathy: Single Institutional Experience of Efficacy and Safety
by: Madalina La Rocca, et al.
Published: (2025-02-01)

Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease
by: Suzuki N, et al.
Published: (2018-04-01)

Iodine contrast should be avoided in patients with thyroid eye disease
by: Jane Z. Spadaro, et al.
Published: (2024-09-01)

Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis
by: Nicole Tsz Yan Wong, et al.
Published: (2023-08-01)

Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves’ disease
by: Laura Carolina Delfino, et al.
Published: (2017-02-01)

Thyroid disease and associated ophthalmopathy
by: Ricardo Concepción, et al.
Published: (2022-04-01)

Targeted immunotherapies for Graves’ thyroidal & orbital diseases
by: Alan Chun Hong Lee, et al.
Published: (2025-03-01)

Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
by: Edelyn Christina, et al.
Published: (2023-06-01)

Clinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery
by: Prabhu Roshan S, et al.
Published: (2012-06-01)

Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves’ disease
by: Nami Suzuki, et al.
Published: (2025-01-01)

Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
by: Jakub Supronik, et al.
Published: (2022-11-01)

Orbital lymphocyte populations in three states of thyroid eye disease
by: Shane M. Griffin, et al.
Published: (2023-09-01)

Are severe forms of thyroid eye disease common in the indian population? Clinical characteristics of 136 patients from a tertiary eye care centre
by: Dhakshini L Subramaniam, et al.
Published: (2023-01-01)

Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review
by: Alexandra Magdalena Ioana, et al.
Published: (2025-02-01)

Treatment of thyroid associated ophthalmopathy : Comparison between radiotherapy with concurrent steroids and three floor orbital decompression
by: Asok Kumar Saha, et al.
Published: (2013-06-01)

How patients experience thyroid eye disease
by: Terry J. Smith, et al.
Published: (2023-11-01)

Application of artificial intelligence in the assessment of thyroid eye disease (TED) - a scoping review
by: Chiaw-Ling Chng, et al.
Published: (2023-12-01)

Hypo vs. hyperthyroid eye disease: is there any difference?
by: Bahram Eshraghi, et al.
Published: (2023-02-01)

Antithymocyte Globulin as Second-Line Therapy in Graves Orbitopathy—Preliminary Results From a Prospective Single-Center Study
by: Monika Sarnat-Kucharczyk, et al.
Published: (2022-05-01)

Effectiveness of educational materials on levels of knowledge of thyroid associated orbitopathy in an endocrinology clinic
by: Wajiha J. Kheir, et al.
Published: (2023-12-01)

Review of thyroid eye disease in euthyroid state with periocular mucinosis
by: Ki-Hun Kim, MD, et al.
Published: (2020-04-01)

The change in the clinical presentation of Graves’ disease: a 30 years retrospective survey in an academic Brazilian tertiary center
by: Wanesa Pinto, et al.
Published: (2020-06-01)

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
by: Dorota Walasik-Szemplińska, et al.
Published: (2019-12-01)

Traumatic Orbital Floor Fracture Causing Therapeutic Orbital Decompression in Thyroid Eye Disease
by: Patrick Buoniconti, et al.
Published: (2022-12-01)

Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves’ Orbitopathy: A Pilot Study
by: Joanna Rymuza, et al.
Published: (2022-07-01)

Thyroid Eye Disease and Glaucoma: A Cross-Sectional Study Comparing Clinical Characteristics and Disease Severity
by: Laura Andreea Ghenciu, et al.
Published: (2024-09-01)

Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts–a possible explanation of the link between smoking and Graves’ ophthalmopathy
by: Chiaw Ling Chng, et al.
Published: (2014-06-01)

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
by: Danilo Villagelin, et al.
Published: (2019-04-01)

Optical coherence tomography angiography in thyroid associated ophthalmopathy: a systematic review
by: Mohammad Taher Rajabi, et al.
Published: (2024-07-01)

Orbital corticosteroid injections for the treatment of active thyroid eye disease
by: Kevin T. Eid, et al.
Published: (2024-01-01)

Systematic review of ocular surface treatments in the setting of thyroid eye disease
by: Anthony Stephen Wong, et al.
Published: (2024-06-01)

Long-term outcomes of inferomedial orbital wall decompression in Graves' ophthalmopathy in an Asian population: A 30-year retrospective study
by: Chu-Ying Chung, et al.
Published: (2024-01-01)

Editorial: News in Graves’ orbitopathy: patients management and treatments
by: Giulia Lanzolla, et al.
Published: (2023-08-01)

Lacrimal gland enlargement as an early clinical or radiological sign in thyroid orbitopathy
by: James Khu, et al.
Published: (2017-04-01)

Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study
by: Marco Aurélio Ferreira Federige, et al.

SELENIUM AND AUTOIMMUNE THYROIDITIS
by: Marco Giammanco
Published: (2023-04-01)